Dark
Light
System
Institutional Investment Manager
Broadfin Capital, LLC
Broadfin Capital, LLC (CIK: 0001511901) incorporated in Delaware, located at 300 Park Avenue, 25th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q4)
Portfolio Summary: 63 holdings with a total value of $900,720,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 STRATA SKIN SCIENCES INC 961,422 423,000 0.05%
2 DEXTERA SURGICAL INC 836,367 803,000 0.09%
3 WINDTREE THERAPEUTICS INC 777,797 972,000 0.11%
4 TRUPANION INC 67,065 1,041,000 0.12%
5 COGENTIX MED INC 753,773 1,515,000 0.17%
6 PALATIN TECHNOLOGIES INC COM 3,846,154 1,943,000 0.22%
7 CONTRAFECT CORP COM 1,429,109 2,501,000 0.28%
8 REDHILL BIOPHARMA LTD 251,509 2,631,000 0.29%
9 NOVADAQ TECHNOLOGIES INC 407,188 2,887,000 0.32%
10 MEDIWOUND ORD 633,102 2,899,000 0.32%
11 NEVRO CORP COM 43,281 3,145,000 0.35%
12 PERNIX THERAPEUTICS HOLDINGS INC 15,500,000 3,565,000 0.40%
13 TENAX THERAPEUTICS INC 1,968,631 3,839,000 0.43%
14 MIRATI THERAPEUTICS INC COM 826,001 3,924,000 0.44%
15 NEXVET BIOPHARMA PUB LTD CO 1,127,200 4,205,000 0.47%
16 Egalet Corp 556,233 4,255,000 0.47%
17 AVIRAGEN THERAPEUTICS INC 3,486,711 4,289,000 0.48%
18 ALCOBRA LTD 2,057,106 4,320,000 0.48%
19 SCYNEXIS INC 1,477,273 4,713,000 0.52%
20 PACIRA PHARMACEUTICALS INC 150,000 4,845,000 0.54% Call
21 GLAUKOS CORP 141,300 4,847,000 0.54%
22 PACIRA PHARMACEUTICALS INC 150,680 4,867,000 0.54%
23 MEDTRONIC PLC 75,000 5,342,000 0.59%
24 ADMA BIOLOGICS, INC. 1,113,293 5,700,000 0.63%
25 CIDARA THERAPEUTICS INC 562,875 5,854,000 0.65%
26 IDERA PHARMACEUTICALS INCORPORATED COM NEW 4,427,745 6,642,000 0.74%
27 Strongbridge Biopharma plc 2,894,581 6,947,000 0.77%
28 CORIUM INTERNATIONAL INC 1,919,721 7,794,000 0.87%
29 ENDOLOGIX INC 1,500,000 8,580,000 0.95%
30 CATALYST PHARMACEUTICALS INC 8,200,000 8,610,000 0.96%
31 ZIMMER BIOMET HLDGS INC 83,500 8,617,000 0.96%
32 SEASPINE HLDGS CORP COM 1,100,007 8,690,000 0.96%
33 AMARIN CORP PLC 2,833,649 8,728,000 0.97%
34 EGALET CORP 10,000,000 8,923,000 0.99%
35 BARD C R INC 40,200 9,031,000 1.00%
36 ZOGENIX INC 766,412 9,312,000 1.03%
37 BIODELIVERY SCIENCES INTL IN 5,398,794 9,448,000 1.05%
38 ADVAXIS INC COM NEW 1,519,259 10,878,000 1.21%
39 DURECT CORP 8,506,229 11,398,000 1.27%
40 IGNYTA INC COM 2,256,546 11,960,000 1.33%
41 PARATEK PHARMACEUTICALS INC 786,134 12,106,000 1.34%
42 ACORDA THERAPEUTICS INC 644,153 12,110,000 1.34%
43 TELIGENT INC NEW 1,931,711 12,769,000 1.42%
44 HORIZON PHARMA PLC 800,000 12,944,000 1.44% Call
45 DERMA SCIENCES ORD 2,562,104 13,323,000 1.48%
46 VERACYTE INC 1,788,266 13,841,000 1.54%
47 MEDICINES CO 436,400 14,811,000 1.64%
48 NOVELION THERAPEUTICS INC 1,948,554 16,407,000 1.82%
49 Aevi Genomic Medicine Inc 3,370,306 17,458,000 1.94%
50 LION BIOTECHNOLOGIES INC COM 2,638,259 18,336,000 2.04%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-17-001744, filed 2017.02.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.